-
Intelligent Non-invasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset.
Neocleous A, Nicolaides K, Schizas C.
IEEE J Biomed Health Inform 2017;21:1271-1279. pdf -
First Trimester Noninvasive Prenatal Diagnosis: A Computational Intelligence Approach.
Neocleous AC, Nicolaides KH, Schizas CN.
IEEE J Biomed Health Inform 2016;20:1427-38. pdf -
Fetal right ventricular contraction and relaxation times at 11-13 weeks' gestation by speckle tracking imaging.
Persico N, Fabietti I, Baffero G, Fedele L, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;43:284-90. pdf -
Meta-analysis of second-trimester markers for trisomy 21.
Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:247-61. -
Screening at 11-13+6 weeks' gestation.
Sonek JD, Nicolaides KH, Janku P.
Ceska Gynekol 2012;77:92-104. -
Nasal bone assessment in fetuses with trisomy 21 at 16-24 weeks of gestation by three-dimensional ultrasound.
Persico N, Molina F, Azumendi G, Fedele L, Nicolaides KH.
Prenat Diagn 2012;32:240-4. -
Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH.
Prenat Diagn 2011;31:7-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Liver volume in trisomy 21 and euploid fetuses at 11 to 13 weeks.
Gielchinsky Y, Zvanca M, Minekawa R, Persico N, Nicolaides KH.
Prenat Diagn 2011;31:28-32. -
Additional first-trimester ultrasound markers.
Sonek J, Nicolaides K.
Clin Lab Med 2010;30:573-92. -
First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
Sonek J, Cicero S, Nicolaides K.
Am J Obstet Gynecol 2007;196:19. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Nasal bone assessment in prenatal screening for trisomy 21.
Sonek JD, Cicero S, Neiger R, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1219-30. -
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:151-5. -
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14. -
Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;26:22-7. -
Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
Nicolaides KH.
Am J Obstet Gynecol 2004;191:45-67. -
Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.
Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:218-23. -
Sonographic markers of fetal aneuploidy: a review.
Cicero S, Sacchini C, Rembouskos G, Nicolaides KH.
Placenta 2003;24:S88-98. -
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH.
Prenat Diagn 2003;23:306-10.